XML 25 R16.htm IDEA: XBRL DOCUMENT
v3.23.1

Stock Compensation | 3 Months Ended
--- | ---
Mar. 31, 2023
Share-based Payment Arrangement [Abstract] |
Stock Compensation | Stock Compensation Overview We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (“RSAs”), restricted stock units (“RSUs”), performance stock units (“PSUs”), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (“ESPP”) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period. Equity Grants During the three months ended March 31, 2023 the Compensation Committee of our Board of Directors (the “Committee”) authorized awards from approved stock incentive plans of RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together total ed 376,000 shares and had an aggregate grant date fair value of $5.0 million. During the three months ended March 31, 2022 the Committee authorized awards from approved stock incentive plans of RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 452,000 shares and had an aggregate grant date fair value of $8.3 million. The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 314,000 shares to certain company officers during the three months ended March 31, 2022. The exercise prices of the options were equal to the closing stock prices on their respective grant dates. The Committee did not authorize any grants of stock options during the three months ended March 31, 2023. Employees purchased common stock totaling 56,000 and 37,000 shares in the three months ended March 31, 2023 and 2022, respectively, through the ESPP. Stock Compensation Expense The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP:
| Three Months Ended March 31, 2023 |  |
| Stock Options |  | ESPP |  |  |  |
Expected life | N/A |  | 0.5 Years |  |  |  |
Expected stock price volatility | N/A |  | 0.66 |  |  |  |
Risk-free interest rate | N/A |  | 4.77% |  |  |  |
The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands):
| Three Months Ended March 31, |  |
| 2023 |  | 2022 |  |  |  |
RSA, RSU, and PSU expense | $ | 2,641 |  |  | $ | 2,768 |  |  |  |  |
Stock option and ESPP expense | 872 |  |  | 572 |  |  |  |  |
Total stock compensation expense | $ | 3,513 |  |  | $ | 3,340 |  |  |  |  |
Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $172,000 and $174,000 in the three months ended March 31, 2023 and 2022, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration